These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 26004537

  • 21. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
    Baxendale RW, Fraser LR.
    Mol Reprod Dev; 2005 Aug; 71(4):495-508. PubMed ID: 15856425
    [Abstract] [Full Text] [Related]

  • 22. Searching the Tritryp genomes for drug targets.
    Myler PJ.
    Adv Exp Med Biol; 2008 Aug; 625():133-40. PubMed ID: 18365664
    [Abstract] [Full Text] [Related]

  • 23. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, Taylor JD, Furdon PJ.
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [Abstract] [Full Text] [Related]

  • 24. The flagellum-mitogen-activated protein kinase connection in Trypanosomatids: a key sensory role in parasite signalling and development?
    Rotureau B, Morales MA, Bastin P, Späth GF.
    Cell Microbiol; 2009 May; 11(5):710-8. PubMed ID: 19207727
    [Abstract] [Full Text] [Related]

  • 25. Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects.
    Patterson S, Wyllie S.
    Trends Parasitol; 2014 Jun; 30(6):289-98. PubMed ID: 24776300
    [Abstract] [Full Text] [Related]

  • 26. Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease.
    Osadchii OE.
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):171-94. PubMed ID: 17373584
    [Abstract] [Full Text] [Related]

  • 27. Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes.
    Blair CM, Baillie GS.
    Biochem Soc Trans; 2019 Oct 31; 47(5):1405-1414. PubMed ID: 31506329
    [Abstract] [Full Text] [Related]

  • 28. Cyclic nucleotide signalling in kidney fibrosis.
    Schinner E, Wetzl V, Schlossmann J.
    Int J Mol Sci; 2015 Jan 22; 16(2):2320-51. PubMed ID: 25622251
    [Abstract] [Full Text] [Related]

  • 29. Acylation in trypanosomatids: an essential process and potential drug target.
    Goldston AM, Sharma AI, Paul KS, Engman DM.
    Trends Parasitol; 2014 Jul 22; 30(7):350-60. PubMed ID: 24954795
    [Abstract] [Full Text] [Related]

  • 30. Treating brain tumors with PDE4 inhibitors.
    Sengupta R, Sun T, Warrington NM, Rubin JB.
    Trends Pharmacol Sci; 2011 Jun 22; 32(6):337-44. PubMed ID: 21450351
    [Abstract] [Full Text] [Related]

  • 31. The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!
    Tagoe DN, Kalejaiye TD, de Koning HP.
    Front Pharmacol; 2015 Jun 22; 6():185. PubMed ID: 26441645
    [Abstract] [Full Text] [Related]

  • 32. Compartmentalization of adenylate cyclase and cAMP signalling.
    Cooper DM.
    Biochem Soc Trans; 2005 Dec 22; 33(Pt 6):1319-22. PubMed ID: 16246108
    [Abstract] [Full Text] [Related]

  • 33. Structure-Based Discovery of PDEs Inhibitors.
    Li L, Chen W, Chen T, Ren J, Xu Y.
    Curr Top Med Chem; 2016 Dec 22; 16(9):917-33. PubMed ID: 26303429
    [Abstract] [Full Text] [Related]

  • 34. Cyclic AMP signalling.
    Fimia GM, Sassone-Corsi P.
    J Cell Sci; 2001 Jun 22; 114(Pt 11):1971-2. PubMed ID: 11493633
    [No Abstract] [Full Text] [Related]

  • 35. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM, Barnes PJ, Meja K, Giembycz MA.
    Mol Pharmacol; 1995 Oct 22; 48(4):747-57. PubMed ID: 7476903
    [Abstract] [Full Text] [Related]

  • 36. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases.
    Baillie GS.
    FEBS J; 2009 Apr 22; 276(7):1790-9. PubMed ID: 19243430
    [Abstract] [Full Text] [Related]

  • 37. Cyclic AMP signaling in trypanosomatids.
    Naula C, Seebeck T.
    Parasitol Today; 2000 Jan 22; 16(1):35-8. PubMed ID: 10637587
    [Abstract] [Full Text] [Related]

  • 38. Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis.
    Balaña-Fouce R, Calvo-Álvarez E, Álvarez-Velilla R, Prada CF, Pérez-Pertejo Y, Reguera RM.
    Mol Biochem Parasitol; 2012 Feb 22; 181(2):85-93. PubMed ID: 22033378
    [Abstract] [Full Text] [Related]

  • 39. Constitutive phosphodiesterase activity restricts spontaneous beating rate of cardiac pacemaker cells by suppressing local Ca2+ releases.
    Vinogradova TM, Sirenko S, Lyashkov AE, Younes A, Li Y, Zhu W, Yang D, Ruknudin AM, Spurgeon H, Lakatta EG.
    Circ Res; 2008 Apr 11; 102(7):761-9. PubMed ID: 18276917
    [Abstract] [Full Text] [Related]

  • 40. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
    Díaz-Benjumea R, Laxman S, Hinds TR, Beavo JA, Rascón A.
    Biochem J; 2006 Oct 15; 399(2):305-14. PubMed ID: 16776650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.